Novel methods to identify and measure catabolism

Area of Science:

• Critical care medicine
• Biochemistry
• Nutritional support

Background:

• Prolonged critical illness is associated with significant muscle wasting and catabolism.
• Identifying reliable biomarkers is crucial for patient management and prognosis.
• Current biomarkers for catabolism in intensive care units (ICUs) require further evaluation.

Purpose of the Study:

• To assess the potential of current biomarkers to characterize patients experiencing prolonged critical illness.
• To evaluate the association of biomarkers with muscle mass and catabolism in ICU populations.
• To determine the clinical applicability of established and novel catabolism biomarkers.

Main Methods:

• Review of existing literature on catabolism biomarkers in critical illness.
• Analysis of the relationship between urea-to-creatinine ratio (UCR) and muscle mass.
• Evaluation of the sarcopenia index (creatinine to cystatin-c ratio) in ICU patients.
• Assessment of growth/differentiation factor-15 (GDF-15) as a biomarker for muscle loss and prognosis.

Main Results:

• Elevated UCR is negatively associated with muscle mass and higher in patients with persistent critical illness.
• Sarcopenia index demonstrates a good correlation with muscle mass in ICU populations.
• Growth/differentiation factor-15 (GDF-15) has shown inconsistent associations with muscle loss and prognosis.

Conclusions:

• Urea-to-creatinine ratio (UCR) is a clinically applicable biomarker for assessing catabolism.
• Sarcopenia index provides a reliable measure of muscle mass and indirect catabolism assessment.
• The clinical utility of novel biomarkers like GDF-15 for catabolism requires further investigation.